Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
4.22 EUR | +0.48% | -20.38% | -49.46% |
Apr. 29 | Biosynex: agreement for ProciseDx in North America | CF |
2023 | Biosynex: merger with Theradiag completed | CF |
1st Jan change | Capi. | |
---|---|---|
-49.46% | 48.27M | |
-1.19% | 12.62B | |
-9.59% | 7.67B | |
+1.95% | 5.41B | |
+0.02% | 4.57B | |
-51.89% | 3.22B | |
+6.42% | 2.59B | |
-14.18% | 2.05B | |
-8.29% | 1.79B | |
+1.67% | 1.76B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- ProciseDx Inc. announced that it expects to receive $8.957 million in funding from Biosynex SA and other investors